John Libbey Eurotext

European Journal of Dermatology

Efficacy of biologics in psoriasis patients under hemodialysis Article à paraître

Illustrations

  • Figure 1
Auteurs
1 CHU Nancy, France
2 CHU Montpellier, France
3 APHP, Paris, France
4 APHM, Marseille, France
5 CHU Besançon, France

The biologics anti-tumour necrosis factor (TNF)-α, anti-interleukin (IL)-12, and IL-23 are indicated for severe-to-moderate plaque psoriasis in patients who fail to respond, or have contraindication, to systemic treatments or phototherapy. Chronic kidney disease (CKD) is a contraindication for many treatments. There are limited data about the use of biologics in CKD. No contraindication nor renal toxicity are reported, and the pharmacokinetic and impact of dialysis on their efficacy are unknown. [...]